The United Kingdom’s health resulator recalled a drug consumed by adults for hypertension after the wrong dose was printed on the box.
The Medicines and Healthcare Products Regulatory Agency (MHRA) also urged patients to check their medication and call their physicians if they have consumed the wrongly-labelled medication.
Boxes of Lercanidipine HCl, manufactured by Recordati Pharmaceuticals, were recalled after they were wrongly labelled as containing 10mg tablets when they contained 20mg pills.
Also Read | Blood pressure control linked to 15% lower dementia risk
The Italian pharmaceutical Recordati said that the error was limited to one batch of lercanidipine, which was first distributed on 10 April. Packs under the recall carry the batch number MD4L07 and have an expiry date of January 2028.
Although the wrong dosage is printed on the front of the affected packages, the correct strength is indicated on the blister strips inside and on the sides of some boxes, BBC reported.
People who have been prescribed 20mg tablets should verify they have the correct strength by checking the printing on the blister strips, the MHRA says. Those who have been prescribed 10mg tablets should seek medical advice immediately. If patients cannot contact their doctors, they can take half of the 20mg tablet as a temporary measure.
In a statement to the BBC, a spokeswoman for Recordati said the company was “working proactively” with the MHRA and would be contacting customers who could have received the affected batch.
The NHS says taking too high a dose of lercanidipine can make you feel dizzy and sleepy.
